Evidence map›Paper›PMID 32909301›Full record

ArticleXenotransplantation2021

Antibody reactivity with new antigens revealed in multi-transgenic triple knockout pigs may cause early loss of pig kidneys in baboons.

Yuichi Ariyoshi, Kazuhiro Takeuchi, Thomas Pomposelli, Dilrukshi K Ekanayake-Alper, Akira Shimizu, Lennan Boyd, Ermance Estime, Mayu Ohta, Arsenoi Asfour, J Scott Arn and 5 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Early Results of an Infant Model of Orthotopic Cardiac Xenotransplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  3. Progress in Porcine Kidney Transplantation to Non-Human Primates.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Developing pig-to-human organ transplants.Science (New York, N.Y.) · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Yuichi AriyoshiColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Kazuhiro TakeuchiColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Thomas PomposelliColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Dilrukshi K Ekanayake-AlperColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Akira ShimizuDepartment of Pathology, Nippon Medical School, Bunkyo-ku, Japan.
Lennan BoydColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Ermance EstimeColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Mayu OhtaColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
Arsenoi AsfourColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
J Scott ArnColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
David AyaresRevivicor Inc., Blacksburg, VA, USA.
Marc LorberLung BioTechnology PBC, Silver Spring, MD, USA.
Megan SykesColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.
David SachsColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.ORCID 0000-0001-9588-8580
Kazuhiko YamadaColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, USA.ORCID 0000-0002-0510-5843
Columbia University · USColumbia University Irving Medical Center · USNippon Medical School · JP

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
National Institute of Allergy and Infectious Diseases P01AI45897NCRR NIH HHS S10 RR027050NIAID NIH HHS P01 AI045897NIH HHS S10 OD020056
6 · The paper itself

Abstract

backgroundRecent advances in gene editing technology have enabled the production of multi-knockout (KO) and transgenic pigs in order to overcome immunologic barriers in xenotransplantation (XTx). However, the genetic manipulations required to produce these changes may have the unintended consequence of producing or revealing neoantigens reactive with natural antibodies present in baboons. In this study, we examined whether the neoantigens that develop in multi-transgenic (mTg) GalT, Cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH), β-1,4-N-acetyl-galactosaminyl transferase 2 (B4) KO pigs can cause rejection of xenografts in baboons.

methodsFive baboons that had <35% cytotoxicity against GalT-KO peripheral blood mononuclear cells (PBMCs) in a pre-screening assay received pig kidneys and vascularized thymic grafts (VT + K) from multi-transgenic hCD47, human thrombomodulin (hTBM), human endothelial protein C receptor (EPCR) with/without hCD46 and hCD55 with GalT-KO/NeuGC-KO/B4-KO (mTg Tri-KO) swine. In order to further examine the effects of anti-donor non-Gal natural antibody (nAb), anti-pig preformed IgM and IgG nAb binding against the GalT-KO PBMCs was compared with the donor-type PBMCs using donor pretransplant sera as well as 5 additional naïve baboon sera by flow cytometric analysis.

resultsFive baboons that received VT + K grafts had stable renal function in the first 11 days (serum creatinine < 1.5 mg/dL). Two of the five baboons had higher binding of preformed IgG to mTg Tri-KO PBMCs than to GalT-KO PBMCs (mTg Tri-KO > GalT-KO), and they rejected their grafts at POD 20. In contrast, the other three baboons demonstrated either mTg Tri-KO = GalT-KO or mTg Tri-KO < GalT-KO, and they maintained renal function 43, 52, and 154 days without rejection. Among 10 baboon sera, two had less antibody binding against PBMCs that were syngeneic to the mTg Tri-KO than against GalT-KO PBMCs (mTg Tri-KO < GalT-KO); three had similar binding to mTg Tri-KO and GalT-KO PBMCs (mTg Tri-KO = GalT-KO); and five had higher binding to m Tg Tri-KO than to GalT-KO PBMCs (mTg Tri-KO > GalT-KO).

conclusionsThese data suggest that neoantigens associated with mTg Tri-KO promote acute xenograft rejection in a pig-to-baboon VT + K XTx model. The screening assays may be useful to select "safe" recipients to receive mTg Tri-KO kidneys.

Indexed as

GalactosyltransferasesLeukocytes, MononuclearAnimalsAnimals, Genetically ModifiedGraft RejectionImmunoglobulin GKidneyPapioSwineTransplantation, HeterologousGalactosyltransferasesImmunoglobulin Gneoantigensnon-Gal natural antibodiespig-to-baboon kidney transplantationxenotransplantation

Identifiers

PMID32909301
PMCPMC8957702
OpenAlexW3086216896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.